HMGCR and hyperlipidemia: Statins are cholesterol inhibitors that selectively inhibit HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl coenzyme A reductase, HMGCR), a rate-limiting enzyme in the mevalonate biosynthesis pathway; they are widely used in treating hyperlipidemia and cardiovascular diseases [7].